Can New EXPAREL Data and Proxy Fight Outcomes Reshape the Case For Investing In Pacira (PCRX)? [Yahoo! Finance]
Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026
Pacira Presents Real-World Data on EXPAREL® Showing Lower Total Healthcare Costs in Outpatient Total Hip and Knee Arthroplasty Procedures
Pacira BioSciences (PCRX) was upgraded by Zacks Research from "strong sell" to "hold".
Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference